Back

Definition and prognosis of tricuspid regurgitation in transthyretin amyloid cardiomyopathy: a multicentre international cohort study

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Tricuspid valve disease and heart failure Tricuspid Valve Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Laurenz Hauptmann

Medical University of Vienna, Vienna (Austria)

5 More presentations in this session

Presentation thumbnail
Association of pressure-adjusted heart rate with heart failure and long-term mortality in patients with significant tricuspid valve regurgitation
Mr C. Kane (Dublin, IE)
Abstract
Presentation thumbnail
FonLiver risk score in patients with tricuspid regurgitation: a 10-year prospective cohort study
Mr J. Zhang (Shenzhen, CN)
Abstract
Presentation thumbnail
Regurgitant fraction by 3DE: outcome-based grading of secondary tricuspid regurgitation across atrial and ventricular phenotypes
Doctor A. Buta (Bucharest, RO)
Abstract
Presentation thumbnail
More than size: right atrial cardiomyopathy mechanistic insights in atrial functional tricuspid regurgitation
Mr E. Gunawan (Barcelona, ES)
Abstract
Presentation thumbnail
Liver-related outcomes in patients with tricuspid regurgitation
Mr J. Zhang (Shenzhen, CN)
Abstract

Access the full session

Session thumbnail
Tricuspid valve disease and heart failure

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Unveiling cardiac amyloidosis, its characteristics and outcomes among patients with mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair
29 August 2022
thumbnail
Congress Presentation
Prognostic value of right ventricular systolic function by speckle tracking echocardiography beyond conventional echocardiography in significant tricuspid regurgitation
27 August 2021
thumbnail
Congress Presentation
Tricuspid regurgitation: a narrative review focused on the missing points in the management of the less noble valve disease, directed to clinical practice
21 May 2023
thumbnail
Congress Presentation
Incidence, predictors and outcome of severe tricuspid regurgitation after transvenous lead extraction: real-world experience from a Swiss nationwide cohort study
13 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources